Chong Kun Dang Holdings Corp. (001630.KS)
001630.KS Stock Price Chart
Explore Chong Kun Dang Holdings Corp. interactive price chart. Choose custom timeframes to analyze 001630.KS price movements and trends.
001630.KS Company Profile
Discover essential business fundamentals and corporate details for Chong Kun Dang Holdings Corp. (001630.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
37.00
CEO
Tae Young Kim
Description
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.
001630.KS Financial Timeline
Browse a chronological timeline of Chong Kun Dang Holdings Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 16 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 12 Aug 2025
Earnings released on 15 May 2025
EPS came in at ₩1.25K , while revenue for the quarter reached ₩246.62B , missing expectations by -12.30%.
Earnings released on 3 Feb 2025
EPS came in at ₩1.01K , while revenue for the quarter reached ₩227.07B , missing expectations by -3.74%.
Dividend declared on 27 Dec 2024
A dividend of ₩1.40K per share was announced, adjusted to ₩1.40K. The dividend was paid on 10 Apr 2025.
Earnings released on 14 Nov 2024
EPS came in at ₩980.00 , while revenue for the quarter reached ₩232.24B , missing expectations by -0.75%.
Earnings released on 14 Aug 2024
EPS came in at ₩3.22K , while revenue for the quarter reached ₩248.44B , beating expectations by +8.97%.
Earnings released on 16 May 2024
EPS came in at ₩1.85K , while revenue for the quarter reached ₩249.99B , beating expectations by +11.11%.
Earnings released on 13 Feb 2024
EPS came in at ₩2.68K , while revenue for the quarter reached ₩224.62B , beating expectations by +0.73%.
Dividend declared on 27 Dec 2023
A dividend of ₩1.40K per share was announced, adjusted to ₩1.40K. The dividend was paid on 5 Apr 2024.
Earnings released on 14 Nov 2023
EPS came in at ₩2.34K , while revenue for the quarter reached ₩223.03B , missing expectations by -4.28%.
Earnings released on 11 Aug 2023
EPS came in at ₩2.22K , while revenue for the quarter reached ₩217.54B , missing expectations by -5.00%.
Earnings released on 15 May 2023
EPS came in at ₩2.51K , while revenue for the quarter reached ₩214.59B , beating expectations by +18.25K%.
Earnings released on 6 Feb 2023
EPS came in at -₩791.67 , while revenue for the quarter reached ₩218.51B .
Dividend declared on 28 Dec 2022
A dividend of ₩1.40K per share was announced, adjusted to ₩1.40K. The dividend was paid on 7 Apr 2023.
Earnings released on 14 Nov 2022
EPS came in at -₩2.12K , while revenue for the quarter reached ₩228.34B .
Earnings released on 15 Aug 2022
EPS came in at -₩2.11K , while revenue for the quarter reached ₩224.35B .
Earnings released on 16 May 2022
EPS came in at ₩395.99 , while revenue for the quarter reached ₩237.75B .
Earnings released on 10 Feb 2022
EPS came in at ₩53.82 , while revenue for the quarter reached ₩213.77B , beating expectations by +50.43%.
Dividend declared on 29 Dec 2021
A dividend of ₩1.40K per share was announced, adjusted to ₩1.40K. The dividend was paid on 8 Apr 2022.
Earnings released on 15 Nov 2021
EPS came in at ₩533.00 , while revenue for the quarter reached ₩231.05B .
Earnings released on 17 Aug 2021
EPS came in at ₩1.35K , while revenue for the quarter reached ₩235.07B .
Earnings released on 17 May 2021
EPS came in at ₩1.27K , while revenue for the quarter reached ₩246.09B .
Earnings released on 9 Feb 2021
EPS came in at ₩6.10K surpassing the estimated ₩2.47K by +147.30%, while revenue for the quarter reached ₩216.31B .
Dividend declared on 29 Dec 2020
A dividend of ₩1.40K per share was announced, adjusted to ₩1.40K. The dividend was paid on 9 Apr 2021.
Earnings released on 30 Oct 2020
EPS came in at ₩3.50K surpassing the estimated ₩2.03K by +72.14%, while revenue for the quarter reached ₩219.67B .
001630.KS Stock Performance
Access detailed 001630.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.